Loading clinical trials...
Loading clinical trials...
A Multi-Arm, Multi-Stage Randomized Controlled Clinical Trial Evaluating Systemic Therapeutic Regimens for the Treatment of Cutaneous Leishmaniasis in Ethiopia
Conditions
Interventions
Sodium Stibogluconate (SSG)
Miltefosine
+3 more
Locations
3
Ethiopia
ALERT Hospital
Addis Ababa, Ethiopia
Arba Minch General Hospital
Arba Minch, Ethiopia
Boru Meda General Hospital
Boru, Ethiopia
Start Date
January 1, 2027
Primary Completion Date
March 1, 2029
Completion Date
August 31, 2029
Last Updated
March 10, 2026
Lead Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions